Cargando…
American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19
Autores principales: | Calello, Diane P., Kazzi, Ziad, Stolbach, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744041/ https://www.ncbi.nlm.nih.gov/pubmed/35006547 http://dx.doi.org/10.1007/s13181-021-00866-z |
Ejemplares similares
-
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
por: Stolbach, Andrew I., et al.
Publicado: (2020) -
ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2020) -
ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
por: Stolbach, Andrew, et al.
Publicado: (2020) -
ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
por: Farmer, Brenna M., et al.
Publicado: (2020) -
Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement
por: Colberg, Sheri R., et al.
Publicado: (2010)